banner news

Singapore, November 5, 2018 – Credo Biomedical Pte. Ltd., a groundbreaking molecular diagnostic company, announced today they will attend the London Vet Show 2018 that will take place in at the ExCeL London November 15th and 16th.


Credo Biomedical will be introducing the QubeMDx, its revolutionary point-of-care molecular diagnostic solution, for the first time to the Veterinary community in the United Kingdom. Using a proprietary Real Time PCR technology, the QubeMDx is an affordable, user friendly and reliable solution that provides diagnostic results in only 15 minutes from a variety of sample types (feces, blood, oral fluid, etc.).


Credo Biomedical will be located at the booth C55, where it will be meeting with individual veterinarians, veterinary associations, and potential business partners.


About Credo Biomedical Pte. Ltd.

Credo Biomedical develops, and manufactures innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of Animal Health, Human Health, and Human Wellness. By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world.